Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 10:12AM ET
348.65
Dollar change
-0.91
Percentage change
-0.26
%
IndexS&P 500 P/E- EPS (ttm)-21.50 Insider Own30.96% Shs Outstand23.42M Perf Week-0.95%
Market Cap9.94B Forward P/E28.68 EPS next Y12.16 Insider Trans-0.08% Shs Float19.69M Perf Month5.54%
Income-637.32M PEG- EPS next Q2.66 Inst Own66.45% Short Float2.94% Perf Quarter8.23%
Sales2.67B P/S3.72 EPS this Y-9.19% Inst Trans1.35% Short Ratio2.90 Perf Half Y-1.08%
Book/sh306.51 P/B1.14 EPS next Y13.63% ROA-4.94% Short Interest0.58M Perf Year-25.98%
Cash/sh56.55 P/C6.17 EPS next 5Y17.80% ROE-6.94% 52W Range261.59 - 494.05 Perf YTD7.98%
Dividend Est.- P/FCF45.56 EPS past 5Y- ROI-6.31% 52W High-29.43% Beta0.87
Dividend TTM- Quick Ratio4.34 Sales past 5Y3.42% Gross Margin53.54% 52W Low33.28% ATR (14)8.26
Dividend Ex-Date- Current Ratio5.83 EPS Y/Y TTM82.31% Oper. Margin14.41% RSI (14)59.81 Volatility3.09% 2.38%
Employees8030 Debt/Eq0.16 Sales Y/Y TTM-4.67% Profit Margin-23.86% Recom1.57 Target Price420.57
Option/ShortYes / Yes LT Debt/Eq0.16 EPS Q/Q-56.32% Payout- Rel Volume0.19 Prev Close349.56
Sales Surprise-0.56% EPS Surprise10.00% Sales Q/Q-6.72% EarningsFeb 15 AMC Avg Volume199.44K Price348.65
SMA203.09% SMA505.53% SMA2001.11% Trades Volume5,846 Change-0.26%
Date Action Analyst Rating Change Price Target Change
Dec-07-23Initiated UBS Buy $395
Jun-16-23Initiated Wells Fargo Overweight $550
Dec-07-22Initiated RBC Capital Mkts Outperform $565
Aug-25-22Initiated Credit Suisse Outperform $715
Jan-28-22Reiterated Citigroup Buy $915 → $750
Jan-08-20Initiated Wells Fargo Overweight $430
Jan-07-20Initiated Citigroup Buy $450
Oct-17-18Initiated Goldman Buy $350
Sep-20-18Initiated Morgan Stanley Equal-Weight $335
Feb-16-18Downgrade CL King Buy → Neutral
Mar-20-24 08:30AM
Mar-12-24 08:27AM
Feb-24-24 03:25PM
Feb-22-24 04:30PM
Feb-15-24 04:15PM
11:32AM Loading…
Feb-05-24 11:32AM
Jan-24-24 05:00PM
Jan-02-24 04:15PM
Dec-12-23 12:42PM
Oct-27-23 11:21AM
Oct-26-23 04:15PM
Oct-05-23 08:30AM
Sep-19-23 05:43AM
Aug-28-23 04:15PM
Aug-03-23 04:15PM
04:15PM Loading…
Jul-26-23 04:15PM
Jul-20-23 04:30PM
Jul-10-23 04:30PM
09:00AM
Jun-26-23 04:00PM
Jun-21-23 08:00PM
Jun-01-23 08:00AM
May-08-23 08:00AM
May-04-23 04:15PM
Apr-26-23 08:00PM
Apr-12-23 04:11PM
Feb-17-23 09:00AM
Feb-16-23 04:05PM
Feb-08-23 08:00AM
Feb-07-23 09:00AM
09:00AM Loading…
Jan-06-23 09:00AM
Jan-04-23 09:00AM
Dec-07-22 02:30PM
07:51AM
Nov-30-22 09:25AM
Nov-20-22 03:48PM
Nov-08-22 01:50PM
Oct-31-22 08:30AM
Oct-28-22 01:01PM
Oct-27-22 05:45PM
04:05PM
Oct-26-22 11:31AM
Oct-18-22 12:01PM
Oct-17-22 08:30AM
Oct-13-22 09:08AM
Oct-12-22 01:10PM
Oct-11-22 04:09PM
07:53AM
Oct-10-22 11:00PM
06:25PM
04:48PM
02:24PM
Oct-03-22 10:00AM
Sep-01-22 10:59AM
10:45AM
Aug-29-22 11:45AM
Aug-25-22 12:20PM
Aug-22-22 12:56PM
Aug-18-22 08:32AM
Aug-15-22 09:09AM
Aug-04-22 03:01PM
Aug-03-22 04:15PM
Jul-29-22 11:28AM
Jul-28-22 05:45PM
04:17PM
Jul-27-22 12:05PM
Jul-22-22 09:49AM
Jul-18-22 04:15PM
Jul-16-22 06:09AM
Jul-13-22 08:15AM
Jun-27-22 11:01AM
08:00AM
Jun-20-22 06:22AM
Jun-17-22 12:38PM
Jun-16-22 09:47AM
Jun-06-22 11:03AM
Jun-03-22 11:31AM
10:26AM
Jun-01-22 12:57PM
May-28-22 08:56AM
May-26-22 10:21AM
10:05AM
10:03AM
May-25-22 10:48AM
09:55AM
08:30AM
May-05-22 11:24AM
Apr-29-22 10:31AM
Apr-28-22 05:45PM
04:15PM
Apr-27-22 10:52AM
Apr-25-22 09:02AM
Apr-21-22 05:17PM
Apr-19-22 10:19AM
Apr-18-22 08:00AM
Apr-13-22 10:10AM
09:09AM
09:04AM
08:54AM
Apr-12-22 10:36AM
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ERNST TIMOTHY SEVP, General Counsel & SecFeb 28 '24Option Exercise326.152,500815,3755,897Feb 29 05:24 PM
ERNST TIMOTHY SEVP, General Counsel & SecFeb 28 '24Sale330.552,500826,3753,397Feb 29 05:24 PM
Crowley MichaelEVP, GBL Commercial OperationsFeb 27 '24Option Exercise215.983,000647,9409,942Feb 28 06:38 PM
Crowley MichaelEVP, GBL Commercial OperationsFeb 27 '24Sale336.003,0001,008,0006,942Feb 28 06:38 PM
WRIGHT DARAEVP, President, CDGDec 16 '23Option Exercise0.0050202,001Dec 19 12:19 PM
WRIGHT DARAEVP, President, CDGDec 12 '23Sale299.161,200358,9921,499Dec 12 07:43 PM
Crowley MichaelEVP, GBL Commercial OperationsNov 28 '23Sale305.10642195,8746,942Nov 28 05:48 PM
SCHWARTZ NORMAN DChairman, President, and CEONov 01 '23Option Exercise133.5766,0008,815,760380,300Nov 02 11:28 AM
Dahowski DianeEVP, Global Supply ChainSep 04 '23Option Exercise0.00600012,155Sep 06 12:56 PM
COREY COLLEENEVP, Global Human ResourcesSep 04 '23Option Exercise0.00600017,431Sep 06 12:52 PM
MAY SIMONEVP, President, LSGSep 04 '23Option Exercise0.0060003,400Sep 06 12:55 PM
Allison SchwartzDirectorSep 04 '23Option Exercise0.008201,210Sep 06 12:58 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 04 '23Option Exercise0.0060007,882Sep 06 01:02 PM
ERNST TIMOTHY SEVP, General Counsel & SecSep 04 '23Option Exercise0.0050003,632Sep 06 01:06 PM
ERNST TIMOTHY SEVP, General Counsel & SecSep 03 '23Option Exercise0.0046403,363Sep 06 01:06 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 03 '23Option Exercise0.0055707,484Sep 06 01:02 PM
Allison SchwartzDirectorSep 03 '23Option Exercise0.005601,151Sep 06 12:58 PM
MAY SIMONEVP, President, LSGSep 03 '23Option Exercise0.0052602,982Sep 06 12:55 PM
COREY COLLEENEVP, Global Human ResourcesSep 03 '23Option Exercise0.00495017,003Sep 06 12:52 PM
Dahowski DianeEVP, Global Supply ChainSep 03 '23Option Exercise0.00495011,727Sep 06 12:56 PM
Last Andrew J.EVP, Chief Operating OfficerSep 02 '23Option Exercise0.0090305,488Sep 06 02:28 PM
Dahowski DianeEVP, Global Supply ChainSep 02 '23Option Exercise0.00361011,357Sep 06 12:56 PM
COREY COLLEENEVP, Global Human ResourcesSep 02 '23Option Exercise0.00361016,633Sep 06 12:52 PM
MAY SIMONEVP, President, LSGSep 02 '23Option Exercise0.0040902,598Sep 06 12:55 PM
Allison SchwartzDirectorSep 02 '23Option Exercise0.004401,113Sep 06 12:58 PM
WRIGHT DARAExecutive Vice PresidentSep 02 '23Option Exercise0.0043302,832Sep 06 01:08 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 02 '23Option Exercise0.0043307,077Sep 06 01:02 PM
Daskal IlanEVP, Chief Financial OfficerSep 02 '23Option Exercise0.0054202,755Sep 06 01:00 PM
RAMALINGAM AJITSVP, Chief Accounting OfficerSep 02 '23Option Exercise0.002410487Sep 06 01:04 PM
ERNST TIMOTHY SEVP, General Counsel & SecSep 02 '23Option Exercise0.0036103,078Sep 06 01:06 PM
ERNST TIMOTHY SEVP, General Counsel & SecSep 01 '23Option Exercise0.0060002,843Sep 06 01:06 PM
RAMALINGAM AJITSVP, Chief Accounting OfficerSep 01 '23Option Exercise0.003420305Sep 06 01:04 PM
Daskal IlanEVP, Chief Financial OfficerSep 01 '23Option Exercise0.001,15002,422Sep 06 01:00 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 01 '23Option Exercise0.0092506,785Sep 06 01:02 PM
WRIGHT DARAExecutive Vice PresidentSep 01 '23Option Exercise0.0092502,540Sep 06 01:08 PM
MAY SIMONEVP, President, LSGSep 01 '23Option Exercise0.0089102,318Sep 06 12:55 PM
COREY COLLEENEVP, Global Human ResourcesSep 01 '23Option Exercise0.00600016,360Sep 06 12:52 PM
Dahowski DianeEVP, Global Supply ChainSep 01 '23Option Exercise0.00849011,110Sep 06 12:56 PM
Last Andrew J.EVP, Chief Operating OfficerSep 01 '23Option Exercise0.001,50004,864Sep 06 02:28 PM
Allison SchwartzDirectorSep 01 '23Option Exercise0.007101,081Sep 06 12:58 PM
ERNST TIMOTHY SEVP, General Counsel & SecAug 30 '23Option Exercise215.982,350507,5534,766Aug 31 02:00 PM
ERNST TIMOTHY SEVP, General Counsel & SecAug 30 '23Sale395.602,350929,6672,416Aug 31 02:00 PM
SCHWARTZ NORMAN DChairman, President, and CEOAug 25 '23Option Exercise93.3849,0724,582,500434,210Aug 28 01:29 PM
ERNST TIMOTHY SEVP, General Counsel & SecAug 23 '23Sale384.69300115,4072,416Aug 23 07:42 PM
Crowley MichaelEVP, GBL Commercial OperationsJun 15 '23Sale379.39500189,6956,040Jun 16 02:02 PM
RAMALINGAM AJITSVP, Chief Accounting OfficerJun 06 '23Sale368.3019873,0530Jun 07 11:31 AM
Last Andrew J.EVP, Chief Operating OfficerApr 29 '23Option Exercise0.001,00004,113May 01 12:51 PM
RAMALINGAM AJITSVP, Chief Accounting OfficerApr 29 '23Option Exercise0.002770294May 01 12:50 PM
Daskal IlanEVP, Chief Financial OfficerApr 08 '23Option Exercise0.0070001,736Apr 11 02:39 PM